227 related articles for article (PubMed ID: 28464886)
1. A lung cancer risk classifier comprising genome maintenance genes measured in normal bronchial epithelial cells.
Yeo J; Crawford EL; Zhang X; Khuder S; Chen T; Levin A; Blomquist TM; Willey JC
BMC Cancer; 2017 May; 17(1):301. PubMed ID: 28464886
[TBL] [Abstract][Full Text] [Related]
2. Lung cancer risk test trial: study design, participant baseline characteristics, bronchoscopy safety, and establishment of a biospecimen repository.
Crawford EL; Levin A; Safi F; Lu M; Baugh A; Zhang X; Yeo J; Khuder SA; Boulos AM; Nana-Sinkam P; Massion PP; Arenberg DA; Midthun D; Mazzone PJ; Nathan SD; Wainz R; Silvestri G; Tita J; Willey JC
BMC Pulm Med; 2016 Jan; 16():16. PubMed ID: 26801409
[TBL] [Abstract][Full Text] [Related]
3. RNAseq analysis of bronchial epithelial cells to identify COPD-associated genes and SNPs.
Yeo J; Morales DA; Chen T; Crawford EL; Zhang X; Blomquist TM; Levin AM; Massion PP; Arenberg DA; Midthun DE; Mazzone PJ; Nathan SD; Wainz RJ; Nana-Sinkam P; Willey PFS; Arend TJ; Padda K; Qiu S; Federov A; Hernandez DR; Hammersley JR; Yoon Y; Safi F; Khuder SA; Willey JC
BMC Pulm Med; 2018 Mar; 18(1):42. PubMed ID: 29506519
[TBL] [Abstract][Full Text] [Related]
4. Technical advance in targeted NGS analysis enables identification of lung cancer risk-associated low frequency TP53, PIK3CA, and BRAF mutations in airway epithelial cells.
Craig DJ; Morrison T; Khuder SA; Crawford EL; Wu L; Xu J; Blomquist TM; Willey JC
BMC Cancer; 2019 Nov; 19(1):1081. PubMed ID: 31711466
[TBL] [Abstract][Full Text] [Related]
5. Derivation of a bronchial genomic classifier for lung cancer in a prospective study of patients undergoing diagnostic bronchoscopy.
Whitney DH; Elashoff MR; Porta-Smith K; Gower AC; Vachani A; Ferguson JS; Silvestri GA; Brody JS; Lenburg ME; Spira A
BMC Med Genomics; 2015 May; 8():18. PubMed ID: 25944280
[TBL] [Abstract][Full Text] [Related]
6. CEBPG transcription factor correlates with antioxidant and DNA repair genes in normal bronchial epithelial cells but not in individuals with bronchogenic carcinoma.
Mullins DN; Crawford EL; Khuder SA; Hernandez DA; Yoon Y; Willey JC
BMC Cancer; 2005 Oct; 5():141. PubMed ID: 16255782
[TBL] [Abstract][Full Text] [Related]
7. Pattern of antioxidant and DNA repair gene expression in normal airway epithelium associated with lung cancer diagnosis.
Blomquist T; Crawford EL; Mullins D; Yoon Y; Hernandez DA; Khuder S; Ruppel PL; Peters E; Oldfield DJ; Austermiller B; Anders JC; Willey JC
Cancer Res; 2009 Nov; 69(22):8629-35. PubMed ID: 19887610
[TBL] [Abstract][Full Text] [Related]
8. TP53 mutation prevalence in normal airway epithelium as a biomarker for lung cancer risk.
Craig DJ; Crawford EL; Chen H; Grogan EL; Deppen SA; Morrison T; Antic SL; Massion PP; Willey JC
BMC Cancer; 2023 Aug; 23(1):783. PubMed ID: 37612638
[TBL] [Abstract][Full Text] [Related]
9. A volatile biomarker in breath predicts lung cancer and pulmonary nodules.
Phillips M; Bauer TL; Pass HI
J Breath Res; 2019 Jun; 13(3):036013. PubMed ID: 31085817
[TBL] [Abstract][Full Text] [Related]
10. Cis-acting genetic variation at an E2F1/YY1 response site and putative p53 site is associated with altered allele-specific expression of ERCC5 (XPG) transcript in normal human bronchial epithelium.
Blomquist TM; Crawford EL; Willey JC
Carcinogenesis; 2010 Jul; 31(7):1242-50. PubMed ID: 20233728
[TBL] [Abstract][Full Text] [Related]
11. A novel serum based biomarker panel has complementary ability to preclude presence of early lung cancer for low dose CT (LDCT).
Wang X; Zhi X; Yang Z; Tian H; Li Y; Li M; Zhao W; Zhang C; Wang T; Liu J; Shen D; Zheng C; Zhao D; Yang S; Qi J; Xin H; Stojadinovic A; Avital I; Lee LJ; Rao J; Zhang W
Oncotarget; 2017 Jul; 8(28):45345-45355. PubMed ID: 28514755
[TBL] [Abstract][Full Text] [Related]
12. Clinical utility of a plasma-based miRNA signature classifier within computed tomography lung cancer screening: a correlative MILD trial study.
Sozzi G; Boeri M; Rossi M; Verri C; Suatoni P; Bravi F; Roz L; Conte D; Grassi M; Sverzellati N; Marchiano A; Negri E; La Vecchia C; Pastorino U
J Clin Oncol; 2014 Mar; 32(8):768-73. PubMed ID: 24419137
[TBL] [Abstract][Full Text] [Related]
13. Normal bronchial epithelial cell expression of glutathione transferase P1, glutathione transferase M3, and glutathione peroxidase is low in subjects with bronchogenic carcinoma.
Crawford EL; Khuder SA; Durham SJ; Frampton M; Utell M; Thilly WG; Weaver DA; Ferencak WJ; Jennings CA; Hammersley JR; Olson DA; Willey JC
Cancer Res; 2000 Mar; 60(6):1609-18. PubMed ID: 10749130
[TBL] [Abstract][Full Text] [Related]
14. Shared Gene Expression Alterations in Nasal and Bronchial Epithelium for Lung Cancer Detection.
AEGIS Study Team
J Natl Cancer Inst; 2017 Jul; 109(7):. PubMed ID: 28376173
[TBL] [Abstract][Full Text] [Related]
15. A Bronchial Genomic Classifier for the Diagnostic Evaluation of Lung Cancer.
Silvestri GA; Vachani A; Whitney D; Elashoff M; Porta Smith K; Ferguson JS; Parsons E; Mitra N; Brody J; Lenburg ME; Spira A;
N Engl J Med; 2015 Jul; 373(3):243-51. PubMed ID: 25981554
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of a plasma biomarker panel for discerning clinical significance of indeterminate pulmonary nodules.
Daly S; Rinewalt D; Fhied C; Basu S; Mahon B; Liptay MJ; Hong E; Chmielewski G; Yoder MA; Shah PN; Edell ES; Maldonado F; Bungum AO; Borgia JA
J Thorac Oncol; 2013 Jan; 8(1):31-6. PubMed ID: 23201823
[TBL] [Abstract][Full Text] [Related]
17. Performance of a multiplexed dual analyte immunoassay for the early detection of non-small cell lung cancer.
Doseeva V; Colpitts T; Gao G; Woodcock J; Knezevic V
J Transl Med; 2015 Feb; 13():55. PubMed ID: 25880432
[TBL] [Abstract][Full Text] [Related]
18. A prediction model based on DNA methylation biomarkers and radiological characteristics for identifying malignant from benign pulmonary nodules.
Xing W; Sun H; Yan C; Zhao C; Wang D; Li M; Ma J
BMC Cancer; 2021 Mar; 21(1):263. PubMed ID: 33691657
[TBL] [Abstract][Full Text] [Related]
19. Translational value of IDH1 and DNA methylation biomarkers in diagnosing lung cancers: a novel diagnostic panel of stage and histology-specificity.
Zang R; Wang X; Jin R; Lei Y; Huang J; Liu C; Zheng S; Zhou F; Wu Q; Sun N; Gao S; He J
J Transl Med; 2019 Dec; 17(1):430. PubMed ID: 31888670
[TBL] [Abstract][Full Text] [Related]
20. Serum mass profile signature as a biomarker of early lung cancer.
Widlak P; Pietrowska M; Polanska J; Marczyk M; Ros-Mazurczyk M; Dziadziuszko R; Jassem J; Rzyman W
Lung Cancer; 2016 Sep; 99():46-52. PubMed ID: 27565913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
